Ribomic Inc.

¥56.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4591Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (22.68%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.59
PE TTM —
TSR TTM (37.78%)
Mkt cap ¥3.181B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥66
18.04%
106.86%
Hold 7|10|8|1|11
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
1.22
1.28
1.23
1.33
34.82%
35.94%
20.85%
19.94%
Revenue¥M
373.8
394.3
395.8
389.4
5.25%
12.45%
8.03%
3.72%
Peers (US$20.20M)
Cap (US$)
PE
20.83M
99.41x
19.27M
15.71x
Capital
TTM
5Y
10Y
Leveragex
0.324
0.049
0.048
EBIT/Intx
0.497
0.183
0.201
Own earn%
(304.99)
32.50
34.06
Sh yield%
18.33
22.61
22.66
Owners
Insiders/Inst%
2.05
51.68
Short interest%
4.46
SBC / revenue%
3.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–10
$1 testx
0.1
Incr. ROIC%
3